Vaxcyte Inc. Common Stock vs Seaboard Corporation Common Stock — how do they compare? Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B), while Seaboard Corporation Common Stock trades at $4,019 (market cap $3.80B). The key difference: Vaxcyte Inc. Common Stock is far larger — about 2.8× Seaboard Corporation Common Stock's market cap, and Seaboard Corporation Common Stock pays a 0.23% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Seaboard Corporation Common Stock for 0 Days on average.
| PCVX | SEB | |
|---|---|---|
Market Cap | $10.51B | $3.80B |
Volume | 2,644,694 | 9,086 |
Sector | Health | Industrials |
52-Week High | $73.82 | $5.96K |
52-Week Low | $40.32 | $3.22K |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.14B | $4.57B |
Dividend Yield | — | 0.23% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →Seaboard Corporation is a diversified agribusiness and transportation company operating through pork production, commodity trading and milling, marine cargo shipping, liquid fuels, power generation, and turkey production segments, including its Seaboard Foods and Butterball businesses. It operates across North America, the Caribbean, South America, Africa, and Europe.
Read more on SEB →